Simultaneous Lengthening of Bilateral Femora and Tibiae in Achondroplastic Patients
This study has been completed.
Sponsor:
Bilen, Fikri Erkal, M.D.
Information provided by:
Bilen, Fikri Erkal, M.D.
ClinicalTrials.gov Identifier:
NCT01328418
First received: April 1, 2011
Last updated: NA
Last verified: April 2011
History: No changes posted
Full Text View Tabular ViewNo Study Results PostedDisclaimerHow to Read a Study Record
  Purpose
The purpose of this study is to determine whether lengthening of both the tibiae and femora in achondroplastic patients is safe and provides reproducible outcome.


Condition	Intervention
SHOX Gene With Short Stature
Procedure: Lengthening over nail

Study Type:	 Interventional
Study Design:	Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title:	Simultaneous Lengthening of Bilateral Femora and Tibiae in Achondroplastic Patients

Resource links provided by NLM:

Genetics Home Reference related topics: metatropic dysplasia pseudoachondroplasia
MedlinePlus related topics: Dwarfism
U.S. FDA Resources 

Further study details as provided by Bilen, Fikri Erkal, M.D.:

Primary Outcome Measures:
Paley's functional scoring system [ Time Frame: Minimum 2 year follow-up ] [ Designated as safety issue: No ]
Paley's functional scoring system evaluates the results after lengthening or deformity correction procedures: residual limb length discrepancy, any brace or other aid usage, joint contracture, pain, soft tissue dystrophism


Enrollment:	22
Study Start Date:	April 2002
Study Completion Date:	March 2011
Primary Completion Date:	March 2008 (Final data collection date for primary outcome measure)
Arms	 Assigned Interventions
Achondroplasia lengthening	 Procedure: Lengthening over nail
External fixator is used to lengthen either the femur or the tibia over an intramedullary nail

   Eligibility

Ages Eligible for Study:  	3 Years to 11 Years
Genders Eligible for Study:  	Both
Accepts Healthy Volunteers:  	No
Criteria
Inclusion Criteria:

Achondroplasia, first lengthening period
Exclusion Criteria:

Previous lengthening
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01328418

Locations
Turkey
Istanbul Medical School
Istanbul, Turkey, 34390
Sponsors and Collaborators
Bilen, Fikri Erkal, M.D.
  More Information

No publications provided 

Responsible Party:	Mehmet Kocaoglu, MD, Professor, Istanbul Medical School
ClinicalTrials.gov Identifier:	NCT01328418     History of Changes
Other Study ID Numbers:	Akondroplazi - Bilen
Study First Received:	April 1, 2011
Last Updated:	April 1, 2011
Health Authority:	Turkey:Institute for Drugs and Medicine Devices

Keywords provided by Bilen, Fikri Erkal, M.D.:
Lengthening

Additional relevant MeSH terms:
Dwarfism
Bone Diseases, Developmental
Bone Diseases
Musculoskeletal Diseases
Genetic Diseases, Inborn
Endocrine System Diseases

ClinicalTrials.gov processed this record on November 22, 2013